Skip to content
Screener

Progyny PGNY Pharmacy benefits services revenue — Revenue

Other product segments

Fertility benefits services revenue
$230.21M+7.6%

Similar metrics at other companies

Weis Markets logo
WMKPharmacy — Revenue
$167.19M+5.4%
Cigna logo
CINetwork Pharmacy — Revenue
$33.33B+9.0%
Cigna logo
CIOther Pharmacy — Revenue
$3.72B+8.4%
GigaCloud Technology logo
GCTService revenues — Revenue
$120.83M+24.7%
Itron logo
ITRIService revenues — Revenue
$109.44M+22.2%
BrightSpring Health Services, Inc. logo
BTSGPharmacy Solutions — Revenue
$3.17B+25.2%

Other financials

Income statement

See full
Revenue$350.5M+5.3%
Gross profit$89.3M+13.1%
Operating income$40.0M+64.2%
Net income$28.1M+63.9%
EPS (diluted)$0.34+78.9%

Balance sheet

See full
Cash & equivalents$152.6M+15.2%
Total debt$27.0M-5.8%
Total equity$453.3M-12.0%
Total assets$715.8M-5.9%

Cash flow

See full
Operating cash flow$50.4M-9.2%
CapEx$6.2M+18.0%
Free cash flow$44.2M-12.0%

Valuation

See full
Market cap$2.37B+17.5%
Enterprise value$2.24B+17.3%
P/E30.1×-7.8×
P/S1.8×+0.2×

Profitability

See full
Gross margin24.6%+2.2pp
Operating margin8.6%+2.4pp
Net margin6%+1.7pp
FCF margin13.6%-1.7pp

Returns & leverage

See full
Return on equity16.2%+5.3pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.6×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Progyny’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 9:00 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001551306-26-000140
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Fertility benefits services revenue (1)$230,209$213,943$439,643$420,348
Pharmacy benefits services revenue120,302118,931239,372236,564
Total revenue$350,511$332,874$679,015$656,912

Item 1. Financial Statements (Unaudited)

FAQ

What is Progyny's pharmacy benefits services revenue — revenue?
Progyny (PGNY) reported pharmacy benefits services revenue — revenue of $120.3M in Q2 2026.
How has Progyny's pharmacy benefits services revenue — revenue changed year-over-year?
Progyny's pharmacy benefits services revenue — revenue increased by 1.2% year-over-year, from $118.93M to $120.3M.
What is the long-term trend for Progyny's pharmacy benefits services revenue — revenue?
Over 4 years (2021 to 2025), Progyny's pharmacy benefits services revenue — revenue has grown at a 33.3% compound annual growth rate (CAGR), from $145.01M to $457.73M.
What does pharmacy benefits services revenue — revenue mean?
This metric represents the total revenue generated from the provision of pharmacy benefit management services, specifically related to fertility-related medications and pharmaceutical support. It reflects the company's ability to capture value through the distribution and management of specialty drugs required for fertility treatments. This revenue stream is a critical component of the integrated benefits model, indicating the scale and adoption of the company's pharmaceutical solutions among employer clients.

Ask your AI about Progyny's pharmacy benefits services revenue — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude